bioecon Member area
Technology · Biochemistry & industrial biotech / Platform chemicals

Arachidonic acid (ARA) microbial synthesis

Arachidonic acid (20:4n-6), the omega-6 long-chain fatty acid of breast milk, produced by submerged fungal fermentation of *Mortierella alpina* and refined into oils and cold-water-soluble powders for infant formula — an industry concentrated in China (Cabio, Kingdomway, Hubei Fuxin) with DSM-Firmenich as the sole end-to-end Western supplier of life's®ARA.

Food Processing & Nutrition Risk: medium Food ingredients US · CN · EU Science: why it works → verified 2026-08-03 · 4 Sources (1 independent)

1 · What it gives

Arachidonic acid (ARA, 20:4n-6) is the principal omega-6 long-chain polyunsaturated fatty acid of human milk, where it appears alongside DHA and supports early brain, visual and immune development. It cannot be economically extracted from plants or fish at food grade, so the commercial supply is microbial: the filamentous fungus Mortierella alpina is grown in submerged fermentation, accumulates ARA-rich single-cell oil inside its mycelium, and the oil is extracted, refined and either sold as a neutral oil or spray-dried into a cold-water-soluble powder for dry-blended formula. This article covers the firms that ferment and refine ARA itself, and it is bounded against two siblings. Microalgal omega-3 owns the omega-3 side — DHA and EPA from Crypthecodinium and Schizochytrium algae; DSM-Firmenich and Kingdomway are tabled there for algal DHA, and they appear again here for a different molecule made by a different organism in a different plant. Precision-fermented infant formula owns the protein side — lactoferrin, HMOs and milk proteins, not lipids. The industry is unusually concentrated and unusually Chinese: three of the four merchant producers are in China, and the West retains a single end-to-end supplier.

The key directions of ARA microbial synthesis are:

  1. Fungal fermentation ARA oil (Mortierella Fermentation): submerged culture of Mortierella alpina on glucose and nitrogen feeds, accumulating ARA as triglyceride in the mycelium, then solvent or mechanical extraction to a crude single-cell oil — the core process for every producer in the table.
  2. Cold-water-soluble ARA powder (Microencapsulated ARA): refined oil emulsified with a protein or starch wall material and spray-dried into a free-flowing powder that survives dry blending into formula base, sold at nominal 10 % ARA alongside 40 % oils.
  3. ARA:DHA ratio formulation (Breast-Milk Lipid Matching): ARA is rarely sold alone — it is supplied against a target ratio to DHA so the finished formula reflects the balance found in human milk, which makes the two lipid lines commercially inseparable even though they come from different organisms.
  4. Regulatory and quality qualification (Novel Food / GRAS / GB 14880): ARA for infant use must clear EU Novel Food authorisation, US FDA GRAS notification and China’s GB 14880 fortifier standard, and — since the 2026 infant-formula recall coverage put supplier testing under scrutiny — must sustain an auditable contaminant and quality regime.

Sectoral value chain#

[strain & inoculum] ──> [submerged fermentation] ──> [biomass recovery]
                                                          │
                                    (Mortierella alpina -> ARA triglyceride)
                                                          │
                                                          ▼
[formula supply] <── [powder microencapsulation] <── [oil extraction & refining]

Value chain levels#

LevelDescriptionKey inputs/outputs
Strain and inoculumselection and propagation of high-yield Mortierella alpina lines and seed culture build-upIn: culture bank, media. Out: production inoculum.
Submerged fermentationaerated stirred-tank culture on glucose/nitrogen feeds, accumulating ARA triglyceride in the myceliumIn: inoculum, glucose, air. Out: ARA-rich fungal biomass.
Biomass recoveryfiltration or centrifugation and drying of mycelium to a stable cake or fermentation powderIn: broth. Out: dried ARA-bearing mycelium.
Oil extraction and refiningextraction of crude single-cell oil, then degumming, bleaching, winterisation and deodorisation to food gradeIn: dried biomass, solvent. Out: refined ARA oil (~40 %).
Powder microencapsulationemulsification with wall material and spray drying to a cold-water-soluble ARA powder for dry blendingIn: refined oil, wall material. Out: ARA powder (~10 %).
Formula supply and qualificationGRAS / Novel Food / GB 14880 dossiers, contaminant testing and supply into infant-formula manufactureIn: oil or powder, dossier. Out: qualified formula ingredient.

Cross-cutting technologies of the sector:

  • Oleaginous fungal cell factories (Single-Cell Oil): Mortierella alpina is one of the few organisms that accumulates a long-chain omega-6 to a commercially useful fraction of its dry mass, which is why the whole industry converges on one genus rather than competing chassis.
  • Lipid refining for infant grade (Food-Grade Refining): the purification train — degumming, bleaching, winterisation, deodorisation — sets the sensory and contaminant profile that infant-formula qualification actually turns on.
  • Spray-dried encapsulation (CWS Powder): wall-material chemistry and drying conditions determine oxidative stability and dispersibility, and are the practical difference between an oil supplier and a formula ingredient supplier.

2 · What it replaces 6 · matched by industry

D3E–Citric acid by Aspergillus niger fermentation instead of extraction from citrus fruit
Replaces: Citric acid extracted from lemons, limes and other citrus (calcium citrate route, Italy and California before 1930)
FOOD
D3E2Glutamate and MSG by bacterial fermentation instead of protein hydrolysis and chemical synthesis
Replaces: Hydrolysis of wheat gluten or soybean protein with hydrochloric acid (1909–1960s); acrylonitrile-based chemical synthesis (Japan, …
FOOD
D3E–Enzymatic high-fructose syrup from starch instead of sucrose and acid hydrolysis
Replaces: Cane and beet sucrose in beverages and processed foods; acid hydrolysis of starch for glucose syrup
FOOD
D2E–Enzymatic degumming (phospholipases) and enzymatic interesterification (immobilized lipases) of edible oils instead of acid–caustic chemical degumming and sodium-methoxide chemical interesterification
Replaces: Phosphoric/citric acid plus caustic soda degumming and neutralization (soapstock, wastewater, oil losses); chemical interesterification with …
FOOD
D1E2Microalgal omega-3 oils (DHA/EPA) instead of fish oil and krill oil
Replaces: Wild-capture fish oil and Antarctic krill oil for omega-3 (food, supplements, infant formula) and part of the aquafeed fish-oil fraction; …
FOOD
D1E–Baking enzymes (fungal amylase, maltogenic amylase, xylanase, glucose oxidase, lipase) plus ascorbic acid instead of potassium bromate and azodicarbonamide as flour treatment agents
Replaces: Potassium bromate (KBrO₃) and azodicarbonamide (ADA) used as oxidizing flour improvers/dough conditioners; part of chemical emulsifier use …
FOOD

3 · How to implement 6 steps

  1. 1
    Strain and inoculumStrains & cell lines
    A high-yield Mortierella alpina line is revived from the culture bank and propagated through seed stages to production volume; the output is a production inoculum.
    Who can do this step matched automatically
    ✓ FSSC 22000 ✓ ISO 22000
    “It specializes in synthetic biology, focusing on the research, development, and industrialization of microbial biomass proteins and recombinant milk proteins.”
    ✓ FSSC 22000 600 tons
    “Synthetic Biology”
    ✓ FSSC 22000 ✓ ISO 22000 30,000 tons per industrial scale
    “2025-04-06 [江苏省人民政府 省级动态 江苏多地做强专业园区促进企业集聚 期待合成生物产业“合成”更多惊喜 — The article highlights Jiangsu’s strong push to cluster synthetic biology industries across multiple cities (Changzhou, …”
    “Tsingke Biotech is a leader in synthetic biology, committed to building a world-class gene factory.”
  2. 2
    Submerged fermentationFermentation & cultivation
    Aerated stirred-tank culture on glucose and nitrogen feeds runs until the mycelium has accumulated ARA-rich triglyceride; the output is ARA-bearing fungal biomass.
    Who can do this step matched automatically
    ✓ FSSC 22000 ✓ ISO 22000 500 m3
    “Technology: microbial fermentation with ~500 m3 fermentation capacity; 15+ patents; developed/upscaled probiotic production technologies.”
    ✓ FSSC 22000 ✓ ISO 22000
    “With expertise in both biomass fermentation and precision fermentation, Changing Bio produces tasteful and versatile non-GMO mycoproteins, as well as a series of dairy proteins, …”
    ✓ FSSC 22000 ✓ ISO 22000 30,000 tons per industrial scale
    “Equipped with most advanced technologies of submerged fermentation, extraction and refining process, our world-class factory is ISO 9001, 14001, FSC 22000 certified and in …”
    ✓ FSSC 22000 600 tons
    “生产与产业化:与合作伙伴(如中科院、美国嘉吉等)共同推进发酵法多不饱和脂肪酸的产业化、建立微生物油脂工厂、实现国内外市场布局。”
  3. 3
    Biomass recovery
    Broth is filtered or centrifuged and the mycelium dried to a stable cake or fermentation powder; the output is dried ARA-bearing biomass.
  4. 4
    Oil extraction and refiningExtraction
    Crude single-cell oil is extracted and taken through degumming, bleaching, winterisation and deodorisation to food grade; the output is refined ARA oil at around 40 %.
    Who can do this step matched automatically
    ScaleUp Bio Singapore
    10,000 L pilot scale
    “Core capabilities span pilot-industrial fermentation and downstream unit operations (centrifugation, TFF, chromatography, solvent extraction, spray/freeze drying) with cGMP …”
    150 m3/month
    “Anand Agro Care, Nashik (India) established in the year 2009 is one of the well-known enterprise highly engrossed in manufacturing and supplying of Bio fertilizers, Bio pesticides, …”
    ✓ BRCGS ✓ HACCP ✓ ISO 22000 228,000 tons
    “It produces bread/Chinese-staple yeasts, yeast extracts, brewing yeasts, yeast protein and other food ingredients, animal feed additives, and nutrition/health products, leveraging …”
    “Botanical Extracts EPZ Ltd (BE) manufactures a range of high quality crude extracts, refined extracts, phytochemicals, steam distilled and cold pressed oils/butters, Natural …”
    “Aum Enzymes is a metabolic engineering firm specializing in generally regarded safe microbial origin Industrial, Food, Feed, Neutraceutical, cosmetic, plant origin [botonical] …”
  5. 5
    Powder microencapsulationFormulation & blending
    Refined oil is emulsified with a wall material and spray-dried into a cold-water-soluble powder for dry blending; the output is ARA powder at around 10 %.
    Who can do this step matched automatically
    ✓ FSSC 22000 ✓ ISO 22000 500 m3
    “This is a satellite blending, mixing and formulation facility, located at Vashind near Shahapur and dedicated to the company’s Animal Nutrition business.”
    1000 tons per year industrial scale
    “2026-07-21 [河北兴柏药业集团公司实现莫能菌素预混剂的规模化生产 农业 企业风采 资讯 发酵工业网 — Hebei Xingbo Pharmaceutical Group (Hebei Granray Bioproducts Co., Ltd.) has achieved large-scale production of canamycin …”
    ✓ FSSC 22000 ✓ ISO 22000
    “Ice Cream Premix Powder”
    ✓ ISO 22000 industrial scale
    “Looking ahead, NHU will remain committed to advancing nutrition and health by leveraging its biotechnology, chemical synthesis, and microencapsulation technology platforms.”
  6. 6
    Formula supply and qualification
    GRAS, Novel Food or GB 14880 dossiers plus contaminant and quality testing accompany delivery into infant-formula manufacture; the output is a qualified formula ingredient supplied against a target ARA:DHA ratio.

4 · Who delivers

Matched suppliers (matched automatically)

CABIO 嘉必优 (SSE 688089)ChinaProduceractive
dsm-firmenichSwitzerlandProduceractive
LipiTune GmbHGermanyProduceractive
Hetang Bioengineering (Wuxi) 禾糖生物ChinaProduceractive
CheckerspotUnited StatesProduceractive
Shandong Chuangxin Humic Acid TechnologyChinaProduceractive
May Seed (May Tohum)TurkeyProduceractive
Ecogreen OleochemicalsIndonesiaProduceractive
ChainCraftNetherlandsProduceractive
KansenBio 绿色康成ChinaProduceractive

In the services and supply catalogue 2 · paid service

Contract manufacturing (CMO/CDMO/toll) · Upstream — fermentation & cell culture

Leading companies and institutes (from the brief)

Company / InstituteCountryKey products / platformsTech featuresStatus 2026
Cabio Biotech🇨🇳 China嘉必优®ARA oil and powderbiosynthetic ω-6 PUFA; first CN product through EU Novel Food + US FDA GRAS; SHA:688362Commercial
Kingdomway🇨🇳 Chinafermentation ARA oil and powderARA among five core series; ARA production-method patent; 250 t/yr Inner Mongolia projectCommercial
Hubei Fuxin Biotechnology🇨🇳 ChinaARA oil and powder, microalgal DHAPUFA specialist, fermentation-produced ARA; Fuxing group subsidiary, HanchuanCommercial
DSM-Firmenich🇳🇱 Netherlandslife’s®ARA / ARASCO® oilplant-based fungal source; sole end-to-end Western ARA supply chainCommercial

5 · Rules & route to market

Route into Russia / EAEU: FOOD · Rospotrebnadzor / EAEU
declaration of conformity, or SGR within 30 calendar days for new/specialized ingredients (plus tests)
Information, not legal advice — confirm the procedure for your product. (2026-10-06)
United States

The United States is the demand and regulatory centre of the ARA trade rather than a production base: infant-formula manufacture and the FDA GRAS pathway sit here, but the fermentation capacity does not.

Martek heritage, FDA GRAS, no domestic merchant producer#

  • The originating platform was American and is now Dutch-owned. ARASCO®, the Mortierella-derived ARA oil that established the category for infant formula, originated with Martek Biosciences and passed to DSM through its 2011 acquisition; the product line is now sold by DSM-Firmenich as life’s®ARA. No independent US merchant ARA fermenter has been confirmed in this screen.
  • GRAS is the gate, not a production incentive. ARA for infant use enters the US market through FDA GRAS notification, which qualifies an ingredient irrespective of where it was fermented — so the regulatory burden falls on the dossier holder while the capacity stays offshore.
  • Supplier scrutiny rose in 2026. Coverage of infant-formula recalls turned attention onto how brands inspect their ARA and DHA suppliers, pushing auditability and contaminant testing up the purchasing criteria for a category that had competed mainly on price and ratio.
European Union

Europe holds the Western incumbent and the strictest authorisation route, but a single production position rather than a cluster.

DSM-Firmenich, EU Novel Food, infant-formula composition rules#

  • DSM-Firmenich (Netherlands) supplies life’s®ARA, also referenced as microbial ARASCO®, from a plant-based fungal source into infant nutrition, and states on its own nutritional-lipids pages that it is the only end-to-end western-based provider of arachidonic acid, not relying on fermentation, crude oil or intermediate materials from third-party suppliers — a vertical-integration claim that is also the clearest statement of how thin the non-Chinese supply base is.
  • Novel Food is the European gate. ARA oil for food use is authorised through Regulation 2015/2283, and Delegated Regulation 2016/127 governs infant-formula composition, so a producer’s European market access is a dossier position as much as a plant position.
  • The lipid pair drives the sale. European formula makers buy ARA against a DHA ratio designed to reflect human milk, which is why the Western supplier of record for ARA is also a major algal-DHA supplier and why the two product lines are marketed together.
China

China is where ARA is actually made. Three of the four merchant producers in the table are Chinese, spanning a listed specialist, a diversified nutrition group and a group subsidiary.

Cabio, Kingdomway, Hubei Fuxin, fermentation capacity#

  • Cabio Biotech (嘉必优, Wuhan, SHA:688362) sells 嘉必优®ARA, describing it as an omega-6 polyunsaturated fatty acid obtained by biosynthetic technology, and states it was the first product of its kind in China to clear both EU Novel Food and US FDA GRAS review. Applications named on its own product pages run from infant formula and health foods to liquid milk, yoghurt and special medical-purpose foods.
  • Kingdomway (金达威, Xiamen, SZ:002626) lists ARA as one of its five core product series alongside coenzyme Q10, vitamin D3, vitamin A and DHA. Its ARA position rests on manufacturing rather than branding: an invention patent for a method of producing arachidonic acid in the field of fermentation engineering was granted to the company and its wholly-owned subsidiary Inner Mongolia Kingdomway Pharmaceutical, and an Inner Mongolia environmental-authority verification record documents a microbial-fermentation ARA project rated at 250 tonnes/year.
  • Hubei Fuxin Biotechnology (湖北福星生物科技, Hanchuan) is a subsidiary of the Fuxing group and describes itself as a specialist in the development, production and sale of polyunsaturated fatty acids, with fermentation-produced arachidonic acid and microalgal DHA as its main products; its catalogue lists ARA oil, ARA powder, DHA oil and microalgal DHA powder.
  • Cargill Alking Bioengineering (嘉吉烯王, Wuhan) appears across Chinese trade listings with specific ARA product codes for oil and powder grades and is credible as a further Wuhan producer, but no reachable page on a domain of its own was found in this screen, so it is named here rather than tabled.

6 · Money: tenders & grants

7 · Tech stack & innovations

  1. The organism is the moat.
    • Mortierella alpina accumulates ARA as a large fraction of mycelial triglyceride, and yield improvement is strain and process work — feed profile, dissolved oxygen, temperature staging — rather than pathway novelty.
    • Because every merchant producer runs the same genus, competition is on titre, refining quality and regulatory position, not on a proprietary route.
  2. Downstream decides the product.
    • Refining sets sensory and contaminant profile: an ARA oil that fails odour or oxidation criteria cannot enter formula regardless of titre.
    • Microencapsulation converts the oil into a dry-blendable powder; nominal grades cluster at ~40 % oil and ~10 % powder, the forms quoted across the trade.
  3. Regulatory assets are production assets.
    • EU Novel Food authorisation and US FDA GRAS notification are slow, dossier-heavy and firm-specific, so clearing both — as Cabio states it did first among Chinese producers — is a durable commercial position.
    • China’s GB 14880 fortifier standard and NMPA formula registration govern the domestic market where most capacity sits.
  4. Vertical integration is the Western answer to scale.
    • DSM-Firmenich’s stated end-to-end control, avoiding third-party fermentation and intermediates, is a supply-security proposition aimed at formula makers who need traceability across the whole chain.

Sources 4 · 1 independent · 3 producer sites

Independent sources 1

  1. Cabio research checked 2026-08-03 · link not kept

Producers' own sites 3

  1. Kingdomway producer checked 2026-08-03 · link not kept
  2. Hubei fuxin producer checked 2026-08-03 · link not kept
  3. Dsm firmenich producer checked 2026-08-03 · link not kept